India Pesticides Ltd Q1 FY27 Earnings Call Analysis

Future growth expectations for India Pesticides Limited: - Anticipate low single-digit revenue growth in FY27, with better performance expected in Q3 and Q4. - Additional revenue of INR 30-40 crores expected from a fungicide molecule in the European Union starting November. - Expansion plans include adding 2-3 new products by FY27, including herbicides and fungicides at Sandila and Hamirpur facilities. - Hamirpur facility set to generate INR 50-60 crores revenue in FY27, with a long-term potential of INR 1,000 crores in 3-4 years through 8-10 production blocks. - Sandila facility expansion aims for INR 1,000 crores turnover in 4 years via multiple blocks. - Export revenue expected to improve with new approvals and increasing global presence. - Capacity utilization currently ~70%, with ongoing capex of INR 70-100 crores per year to support growth.

The transcript does not explicitly mention the current or expected order book or pending orders in precise figures. However, key points related to demand and sales outlook include: - Soft domestic demand impacted Q1 FY27 revenue due to deficient rainfall affecting key herbicides (e.g., Pretilachlor). - Export revenues remain stable and slightly improved versus last year, contributing about 35% of total revenue. - Approval from the European Union for a fungicide product is expected to boost export revenues by INR 30-40 crores annually. - New molecule additions and capacity expansions at Hamirpur and Sandila facilities aim to reduce dependence on single products and grow revenue streams. - Sales for the EU molecule approval expected to commence from November 2026, following customer approvals. - Anticipated better demand in Q3 and Q4 FY27 with sale of intermediates and new product launches. No specific orderbook or pending order value disclosed.